Consult your healthcare provider before starting any treatment, especially if you have conditions like diabetes, kidney disease, or are pregnant or breastfeeding.
There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved
(38) measured and then compared occipital cortex (COC) GSH levels in unmedicated adults with MDD to healthy participants and found 21% lower GSH levels in MDD patients
Most clinical experts recommend aiming for 80 to 100 ounces of water daily
Alternative Tip : Try a healthier version, like a crustless pumpkin pie sweetened with a natural alternative or a small fruit salad with cinnamon
Metabolism in 2013: The gut microbiota manages host metabolism
